Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-22

Clinical Trial Update: Testosterone Treatment for Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on testosterone treatment for multiple sclerosis (Phase 1/2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-22